VERORAB is indicated for the prevention of rabies in children and adults. It can be used before or after exposure to the rabies virus, as a primary vaccination or as a booster dose.
Pre-exposure rabies prevention (pre-exposure vaccination): Pre-exposure vaccination should be offered to subjects at high risk of contamination by the rabies virus.
All those at permanent risk, such as the personnel of diagnostic, research or production laboratories working with the rabies virus, should be vaccinated. Immunity should be maintained by booster doses (see How to use VERORAB under Dosage & Administration).
Vaccination is also recommended for the following categories, given the frequency of exposure to risk: Veterinarians and veterinarians' assistants, animal handlers (including those manipulating bats) and forest warden (gamekeepers), taxidermists.
People in contact with potentially rabid animal species (such as dogs, cats, skunks, raccoons and bats).
Adults and children living in or traveling to enzootic areas.
Post-exposure rabies prevention (post-exposure vaccination): Vaccination should be initiated immediately at the slightest risk of rabies contamination. It must imperatively be performed in a rabies centre under medical supervision.
Post-exposure treatment includes local non-specific treatment of the wound, vaccination and passive immunisation with rabies immunoglobulins. The treatment should be adapted to the nature of the contact or of the wound, the condition of the animal and the patient's rabies vaccination status (see How to use VERORAB under Dosage & Administration).
Local treatment of the wound must be performed in all cases.